Parkside Financial Bank & Trust Has $27,000 Position in Teleflex Incorporated (NYSE:TFX)

Parkside Financial Bank & Trust trimmed its position in Teleflex Incorporated (NYSE:TFX) by 46.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 108 shares of the medical technology company’s stock after selling 94 shares during the quarter. Parkside Financial Bank & Trust’s holdings in Teleflex were worth $27,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the company. Venturi Wealth Management LLC grew its stake in shares of Teleflex by 33.3% in the fourth quarter. Venturi Wealth Management LLC now owns 184 shares of the medical technology company’s stock valued at $46,000 after acquiring an additional 46 shares in the last quarter. Huntington National Bank grew its position in shares of Teleflex by 26.5% during the 3rd quarter. Huntington National Bank now owns 253 shares of the medical technology company’s stock worth $50,000 after purchasing an additional 53 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd increased its holdings in shares of Teleflex by 1.5% during the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 3,767 shares of the medical technology company’s stock worth $740,000 after purchasing an additional 56 shares during the period. Lindbrook Capital LLC raised its position in shares of Teleflex by 75.3% in the fourth quarter. Lindbrook Capital LLC now owns 135 shares of the medical technology company’s stock valued at $34,000 after buying an additional 58 shares in the last quarter. Finally, Asset Management One Co. Ltd. grew its position in Teleflex by 0.3% during the third quarter. Asset Management One Co. Ltd. now owns 19,230 shares of the medical technology company’s stock worth $3,777,000 after buying an additional 60 shares in the last quarter. Institutional investors own 95.62% of the company’s stock.

Analyst Ratings Changes

TFX has been the subject of a number of recent analyst reports. Truist Financial cut their target price on Teleflex from $270.00 to $265.00 and set a “hold” rating for the company in a research report on Friday, February 23rd. Royal Bank of Canada reduced their price objective on shares of Teleflex from $272.00 to $265.00 and set an “outperform” rating on the stock in a research note on Friday, February 23rd. StockNews.com cut shares of Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, February 23rd. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $285.00 price target on shares of Teleflex in a report on Friday, February 23rd. Four analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat, Teleflex presently has an average rating of “Moderate Buy” and an average target price of $267.50.

Insiders Place Their Bets

In other news, VP Cameron P. Hicks sold 7,401 shares of the business’s stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $225.00, for a total value of $1,665,225.00. Following the transaction, the vice president now directly owns 10,050 shares of the company’s stock, valued at approximately $2,261,250. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.43% of the company’s stock.

Teleflex Stock Performance

NYSE TFX opened at $206.71 on Friday. The firm has a market capitalization of $9.74 billion, a PE ratio of 27.45, a price-to-earnings-growth ratio of 1.98 and a beta of 1.11. The business’s 50-day moving average price is $221.23 and its two-hundred day moving average price is $225.79. The company has a current ratio of 2.32, a quick ratio of 1.29 and a debt-to-equity ratio of 0.39. Teleflex Incorporated has a 12 month low of $177.63 and a 12 month high of $276.43.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, February 22nd. The medical technology company reported $3.38 earnings per share for the quarter, beating analysts’ consensus estimates of $3.26 by $0.12. The business had revenue of $773.90 million during the quarter, compared to the consensus estimate of $769.01 million. Teleflex had a net margin of 11.98% and a return on equity of 14.98%. The company’s revenue for the quarter was up 2.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $3.52 EPS. On average, analysts expect that Teleflex Incorporated will post 13.73 EPS for the current year.

Teleflex Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Friday, March 1st were given a dividend of $0.34 per share. The ex-dividend date was Thursday, February 29th. This represents a $1.36 dividend on an annualized basis and a yield of 0.66%. Teleflex’s dividend payout ratio (DPR) is currently 18.06%.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.